Epigenetic Skincare: The Next Generation of Smart Anti-Aging Ingredients
Anti-Aging Reimagined: Why Traditional Approaches Are No Longer Enough
For decades, cosmetic anti-aging research has focused primarily on treating visible signs of skin aging. The goal was to smooth out wrinkles, reduce age spots, and improve the skin’s moisture levels. Active ingredients such as retinol, vitamin C, peptides, and hyaluronic acid have undoubtedly set new standards in these areas and remain among the most important components of modern skincare to this day.
However, in recent years, the scientific perspective on the aging process has fundamentally changed. Whereas in the past the focus was mainly on treating individual symptoms, today the biological causes of skin aging have taken center stage. International research groups are increasingly exploring how to preserve the skin’s natural vitality for as long as possible, rather than merely concealing damage that has already occurred.
This is precisely where epigenetic skincare comes in. It takes a significantly more comprehensive approach than traditional anti-aging concepts. The goal is not to reduce individual wrinkles in the short term, but rather to specifically support the skin’s natural repair, regeneration, and protective mechanisms. Modern active ingredients influence biological signaling pathways responsible for collagen synthesis, DNA repair, inflammation regulation, and the maintenance of the extracellular matrix. This gives rise to a new approach often summarized under the terms Skin Longevity or Healthy Aging.
Epigenetic skincare is thus emerging as one of the most exciting fields of innovation in modern cosmetics. It combines insights from molecular biology, cell research, epigenetics, and dermatology into a holistic concept that goes far beyond traditional anti-aging strategies.
From Anti-Aging to Healthy Aging
Aging skin does not change only on its surface. Rather, numerous biological processes take place internally that influence one another.
With increasing age, the following functions, among others, continuously decline:
- Collagen and elastin synthesis
- Cell communication
- DNA repair
- Antioxidant protection
- Regeneration of the extracellular matrix (ECM)
- Stem cell activity
- Skin thickness
- Elasticity
- Barrier function
At the same time, inflammatory processes and oxidative stress continue to increase. The result is wrinkles, loss of elasticity, diminished firmness, loss of volume, and an overall reduction in the skin’s resilience to external stressors.
Healthy Aging therefore takes a different approach than traditional anti-aging. Instead of treating only visible signs of skin aging, the goal is to positively influence as many biological aging processes as possible at an early stage. The skin should retain its natural functions for as long as possible and maintain its resilience against environmental stressors.
Epigenetic skincare provides entirely new tools for this purpose.
What does epigenetics mean?
The term epigenetics describes changes in gene activity without altering the actual DNA sequence.
Simply put, every skin cell contains the same genetic information. However, epigenetics determines which genes are actually active and which are silenced. It acts like a biological dimmer switch or toggle that activates genes to a greater or lesser extent.
This regulation occurs through, among other things:
- Histone acetylation
- Histone deacetylation
- DNA methylation
- microRNAs (miRNAs)
- RNA interference
MicroRNAs, in particular, have received enormous attention in recent years. They regulate hundreds of genes simultaneously and influence, among other things:
- Collagen formation
- Elastin synthesis
- Inflammatory processes
- pigmentation
- cell communication
- wound healing
- skin aging
These findings form the scientific basis of modern epigenetic skincare.
Why is epigenetic skincare so interesting?
While traditional active ingredients often stimulate individual metabolic processes, epigenetic active ingredients intervene much earlier in biological regulatory mechanisms.
For example, they can:
- support the formation of new collagen fibers,
- promote elastin synthesis,
- stabilize the extracellular matrix,
- activate DNA repair mechanisms,
- reduce oxidative stress,
- alleviate chronic inflammation,
- and improve communication between skin cells.
This results in a holistic approach to the long-term maintenance of healthy skin function.
Epigenetic skincare is therefore considered one of the most important developments in modern active ingredient research.
Skin Longevity – The Longevity of the Skin
The term Skin Longevity describes the skin’s ability to maintain its biological performance for as long as possible.
This is not about preventing aging, but rather about preserving healthy skin functions over many years.
Among the most important goals are:
- a stable skin barrier
- intact DNA
- functional cell communication
- healthy fibroblasts
- high-performing stem cells
- a stable extracellular matrix
- low levels of chronic inflammation
- high regenerative capacity
Skin Longevity thus combines insights from aging research with modern cosmetic active ingredients and forms the scientific basis of epigenetic skincare.
The Hallmarks of Aging
A decisive breakthrough in aging research was achieved in 2013 with the publication of the so-called Hallmarks of Aging by López-Otín and colleagues. These describe the fundamental biological mechanisms that govern the aging process.
Among the most important are:
- genomic instability
- telomere shortening
- epigenetic changes
- Loss of protein homeostasis
- Mitochondrial dysfunction
- Stem cell depletion
- Cellular senescence
- Chronic inflammation (“inflammaging”)
- Impaired cell communication
Four of these processes are of particular importance in cosmetics:
Epigenetic changes: Genes for collagen, elastin, or antioxidant defense systems become less active with age.
Cell senescence: Old cells that can no longer divide—often referred to as “zombie cells”—remain in the tissue and continuously release pro-inflammatory signaling molecules.
Chronic inflammation: Even mild but persistent inflammatory processes accelerate the breakdown of the skin’s structure.
Genomic instability: UV radiation, air pollution, and oxidative stress continuously cause DNA damage, which becomes increasingly difficult to repair with age.
Modern approaches to epigenetic skincare aim to specifically and positively influence these very mechanisms.
The extracellular matrix—the foundation of youthful skin
An essential component of healthy skin is the extracellular matrix (ECM). It forms the three-dimensional scaffold of the dermis and gives the skin its firmness, elasticity, and mechanical stability.
Its most important components include:
- Type I collagen
- Type III collagen
- Type IV collagen
- Elastin
- Fibrillin
- Fibronectin
- Laminins
- Proteoglycans
- Hyaluronic acid
With advancing age, however, the balance between the formation and breakdown of this matrix shifts. While matrix metalloproteinases (MMPs) increasingly break down collagen, the synthesis of structural proteins simultaneously declines. The result is a loss of elasticity, the formation of wrinkles, and sagging skin.
A central goal of epigenetic skincare is therefore to stabilize the extracellular matrix over the long term and support its natural regeneration.
The Dermal-Epidermal Junction—the Underestimated Link
Between the epidermis and the dermis lies the so-called dermal-epidermal junction (DEJ). It connects both layers of the skin and ensures optimal communication between keratinocytes and fibroblasts.
With increasing age, this boundary layer loses stability. The consequences are:
- reduced mechanical strength
- slowed cell communication
- reduced nourishment of the epidermis
- declining elasticity
- increasing wrinkle formation
For this reason, many modern active ingredients no longer focus exclusively on collagen or hyaluronic acid, but rather specifically on stabilizing the DEJ and the extracellular matrix. Today, this approach is considered an essential component of epigenetic skincare and forms the basis of innovative skin longevity concepts.
Now that the biological foundations of epigenetic skincare have been explained, the crucial question arises: Which cosmetic active ingredients are actually capable of positively influencing these complex signaling pathways?
In recent years, numerous innovative active ingredient systems have been developed that go far beyond the traditional stimulation of collagen production. Rather than merely stimulating individual metabolic processes, they specifically intervene in molecular regulatory mechanisms and support the skin’s natural repair and regeneration processes.
Two particularly interesting examples of this new generation of active ingredients are RNActivate™ and TensylPro™. Although they take different approaches, they complement each other perfectly within modern skin longevity concepts.
RNActivate™ – RNA Technology for a New Generation of Skincare
RNActivate™ is one of the world’s first cosmetic active ingredients to specifically target RNA interference (RNAi) and the regulation of a wrinkle-associated microRNA. While many anti-aging active ingredients attempt to indirectly stimulate collagen production, RNActivate™ intervenes much earlier in the biological regulatory process and modulates an epigenetic signaling pathway that influences the formation of important structural proteins in the skin.
What are microRNAs?
MicroRNAs (miRNAs) are short, non-coding RNA molecules that act as natural regulators of gene expression. They bind to specific messenger RNAs (mRNAs) and control whether or not a particular protein is produced. Even small changes in individual microRNAs can simultaneously influence the activity of numerous genes.
As we age, the concentrations of various microRNAs change. Some of these specifically inhibit the formation of collagen, elastin, and fibrillin—three crucial structural proteins of the extracellular matrix. RNActivate™ uses a proprietary delivery system to introduce so-called AntagomiRs into the skin. These neutralize the wrinkle-associated microRNA and thereby support the natural synthesis of these structural proteins.
Mechanism of Action
RNActivate™ specifically supports:
- Type I collagen
- Elastin
- Fibrillin-1
- Stabilization of the extracellular matrix
- Improvement in skin firmness
- Reduction of age-related wrinkle formation
In this way, the active ingredient simultaneously addresses several key mechanisms of epigenetic skincare.
Study Results
The efficacy of RNActivate™ was investigated in cell cultures, reconstructed skin models, ex vivo skin preparations, and clinical studies. The investigations showed, among other things:
- Increased collagen I production
- Increased elastin synthesis
- Increased fibrillin concentrations
- Improved skin firmness
- Increased skin elasticity
- Visible reduction in crow’s feet
- Reduction in forehead wrinkles
- Improvement in skin surface and structure
- Increase in skin thickness
It is particularly noteworthy that RNActivate™ not only influences individual biomarkers but also modulates an overarching epigenetic signaling pathway. This allows for the simultaneous support of multiple structural proteins in the skin.
Recommended usage concentration
According to the manufacturer, the recommended usage concentration is approximately 1–3%, depending on the specific formulation, retail price, and product category.
Suitable Product Concepts
RNActivate™ is particularly suitable for:
- Premium anti-aging serums
- Skin longevity serums
- Night care
- Eye care
- Regenerating ampoules
- Intensive treatment regimens
The active ingredient unfolds its full potential especially when combined with peptides, hyaluronic acid, or DNA repair agents.
Expert Tip
RNActivate™ is an excellent fit for formulations intended to be marketed under the terms “RNA Skincare”, “Gene-Inspired Cosmetics”, or “Next Generation Anti-Aging”. These terms are becoming increasingly important, particularly in the premium segment.
TensylPro™ – Skin Longevity Through Stabilization of the Dermal-Epidermal Junction
While RNActivate™ primarily targets RNA signaling pathways, TensylPro™ takes a structural approach. The active ingredient focuses on the dermal-epidermal junction (DEJ) and the extracellular matrix—two areas that play a key role in the skin’s firmness, elasticity, and tone.
The DEJ connects the epidermis and dermis, ensuring the exchange of substances and information between the two skin layers. With age, this boundary layer flattens and loses stability, causing the skin to lose its tone and elasticity.
Two Plants—One Synergistic Active Ingredient
TensylPro™ is based on a combination of two plant extracts:
- Rumex acetosella (small sorrel)
- Pinus massoniana (Masson pine)
Both plants are rich in flavonoids, proanthocyanidins, and other phytochemicals with antioxidant and anti-inflammatory properties. Particularly noteworthy is the sustainable approach: The extract from Masson pine is derived from bark that is a byproduct of the timber industry and is thus meaningfully upcycled.
Mechanism of Action
TensylPro™ specifically strengthens the skin’s architecture by:
- Increasing type III and type IV collagen synthesis
- Promoting elastin formation
- Activating laminins
- Boosting fibronectin production
- Supporting LOXL enzymes for the cross-linking of collagen and elastin
- Increasing syndecan-1
- inhibiting heparanase
- inhibiting hyaluronidase-2
- antioxidant effects
- anti-inflammatory properties
Thus, TensylPro™ not only acts on individual structural proteins but also stabilizes the entire extracellular matrix and, in particular, the dermal-epidermal junction.
Collagen Banking—A Current Trend
An exciting trend in recent years is so-called collagen banking. The goal is to preserve the body’s natural collagen reserves as early as possible and slow their breakdown, rather than treating wrinkles that have already formed.
TensylPro™ is ideally suited for this approach, as the active ingredient both supports the formation of important structural proteins and reduces the enzymatic breakdown of the extracellular matrix.
Study Results
Preclinical studies showed, among other things:
- increased expression of type III collagen
- increased expression of type IV collagen
- increased elastin formation
- increased laminin production
- increased fibronectin synthesis
- improved LOXL expression
- inhibition of elastase
- protection against oxidative stress
- reduction of inflammatory cytokines
- upregulation of a total of 22 skin-related genes.
In addition, clinical improvements were observed in:
- skin firmness
- skin elasticity
- skin texture
- visible tightening
- wrinkle reduction
.
Recommended usage concentration
Depending on the formulation, the manufacturer recommends a usage concentration of 1–3%. This concentration allows for good integration into emulsions, serums, and gel formulations.
Suitable Product Formulations
TensylPro™ is particularly suitable for:
- Firming Cream
- Lifting Serum
- Neck & Décolleté Cream
- Eye Lift Gel
- Skin Longevity Serum
- Premium Day Cream
- Anti-Gravity Care
- Post-Menopause Skincare
Why RNActivate™ and TensylPro™ Work So Well Together
Although both active ingredients have different modes of action, they complement each other perfectly. RNActivate™ acts at the level of gene regulation and supports the synthesis of key structural proteins. TensylPro™ then stabilizes the structures formed within the extracellular matrix and strengthens the dermal-epidermal junction.
This combination thus addresses both the molecular regulation and the structural integrity of the skin —two key mechanisms of modern epigenetic skincare. Complemented by active ingredients for DNA repair, epigenetic senescence regulation, and volume restoration, this creates a holistic skin longevity concept that goes far beyond traditional anti-aging strategies.
With RNActivate™ and TensylPro™, two active ingredient approaches have already been introduced that target microRNA signaling pathways, the extracellular matrix, and the dermal-epidermal junction. However, for a comprehensive skin longevity concept, it is not enough to solely support the formation of collagen and elastin.
Epigenetic changes, the accumulation of senescent cells, declining DNA repair mechanisms, oxidative stress, and age-related loss of subcutaneous volume also shape the appearance of mature skin. This is precisely where DermalRx® Acetygen®, DermalRx® FSE, and Volpura® EPO come into play.
Together, these active ingredients open up new possibilities for epigenetic skincare that not only addresses individual wrinkles but also takes into account cellular health, skin architecture, resilience, and facial contours simultaneously.
DermalRx® Acetygen® – Epigenetic Regulation for More Youthful Cell Function
DermalRx® Acetygen® is based on a synergistic combination of extracts from:
- Agrimonia eupatoria, common agrimony,
- Ampelopsis grossedentata, a flavonoid-rich plant species also known as vine tea.
The manufacturer specifically identifies dihydromyricetin, myricetin, and other flavonoids as key bioactive plant compounds. This active ingredient was developed to support the skin’s intrinsic monitoring, repair, and remodeling processes.
The recommended usage concentration is 1 to 3%. The INCI composition is:
Water, Butylene Glycol, Agrimonia Eupatoria Extract, Ampelopsis Grossedentata Leaf Extract.
The HAT/HDAC Switch
DNA is not present in a free state within the cell nucleus but is wrapped around so-called histone proteins. Depending on how tightly or loosely this structure is organized, certain genes can be read more or less efficiently.
During histone acetylation, acetyl groups are attached to histones. This loosens the chromatin structure, making genes more accessible. Histone acetyltransferases (HATs) promote this process. Histone deacetylases (HDACs), on the other hand, remove the acetyl groups and can reduce gene activity.
DermalRx® Acetygen® is described by the manufacturer as an HDAC-modulating or HDAC-inhibiting active ingredient. This is intended to maintain histone acetylation and support the expression of selected genes relevant to young and healthy skin. This is a good example of how epigenetic skincare is designed to influence gene activity without altering the DNA sequence itself.
Support in Managing Senescent Cells
As we age, senescent cells accumulate in the tissue. These cells no longer divide but remain metabolically active. Through the so-called Senescence-Associated Secretory Phenotype (SASP), they can release inflammatory signaling molecules and matrix-degrading enzymes. As a result, they can exacerbate inflammaging, collagen degradation, and functional loss in the surrounding tissue. The role of senescent fibroblasts and their inflammatory and matrix-degrading signals is now considered a key component of skin aging research.
DermalRx® Acetygen® is designed to support the skin’s natural cellular surveillance and elimination of senescent cells. However, in a cosmetic context, one should not speak of a complete “removal of zombie cells” or a medical senolytic effect. For legally compliant cosmetic communication, formulations such as the following are appropriate:
- supports the skin’s natural renewal processes,
- promotes a balanced skin environment,
- supports the regeneration of stressed skin,
- contributes to a more vibrant and youthful complexion.
Results of Gene Expression Analysis
According to the manufacturer, DermalRx® Acetygen® increased the expression of 16 genes associated with healthy and youthful-looking skin. These include genes for:
- Collagen types I, III, IV, and VII,
- fibrillin,
- fibronectin,
- decorin,
- versican,
- hyaluronic acid synthase 2,
- stress protection and antioxidant defense,
- and the organization and protection of the extracellular matrix.
Thus, the active ingredient combines epigenetic regulation with ECM protection, skin plumping, stress defense, and remodeling. The underlying results are derived from the manufacturer’s studies and must always be validated for specific product claims based on the final formulation and appropriate efficacy tests.
Suitable Applications
DermalRx® Acetygen® is ideal for, among other things:
- skin longevity serums,
- regenerating night care,
- post-sun products,
- barrier repair care,
- products for stressed and sensitive skin,
- anti-inflammaging formulations,
- treatment regimens, and highly concentrated ampoules.
DermalRx® FSE – Supporting Natural DNA Repair
Our skin is exposed daily to UV radiation, reactive oxygen species, air pollutants, and other components of the exposome. UVB radiation can directly damage DNA and, among other things, generate cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts. At the same time, oxidative stress can cause additional DNA alterations.
Cells possess various repair mechanisms. Particularly relevant for UV-induced damage is nucleotide excision repair, or NER for short. The efficacy of such repair processes can decline with age, while damage accumulates over the course of a lifetime. The scientific literature also describes UV damage and alterations in the long-lived collagen and elastin structures as key factors in skin aging.
Fermented Brown Algae as a Starting Material
DermalRx® FSE is a fermented active ingredient derived from Sargassum vulgare. The brown algae is bioconverted using a proprietary strain of Saccharomyces cerevisiae. This process is intended to produce or enrich bioavailable phlorotannins and other active components.
Phlorotannins are polyphenolic compounds derived from brown algae that are associated with antioxidant, anti-inflammatory, and photoprotective properties. The active ingredient is water-soluble or water-miscible and is specified with a recommended usage concentration of 0.5 to 2%. It should be added during the final manufacturing step at temperatures below 50 °C and protected from prolonged direct exposure to light.
Results on the Repair of UV-Induced DNA Damage
In vitro, human fibroblasts and keratinocytes were exposed to UVB radiation and subsequently treated with DermalRx® FSE.
Fibroblast treatment with active ingredient concentrations of 0.013% and 0.04% resulted in reductions in CPD levels of 29% and 56%, respectively, after 24 hours compared with the untreated control. In keratinocytes, reductions in CPD values of 69% and 72% were observed at active ingredient concentrations of 0.067% and 0.13%, respectively.
In a further ELISA analysis, a concentration of 0.13% in fibroblasts reduced CPD values by 50% and 6-4 photoproducts by 70%. Within the cell model used, these results suggest support for the repair of UV-induced DNA lesions.
It is important to note that the concentrations mentioned refer in part to cell culture experiments and should not be equated with the concentration of the commercial product used in a finished cosmetic formulation.
MicroRNAs, Oxidative Stress, and Anti-Pollution
According to the manufacturer, DermalRx® FSE also influenced microRNAs associated with DNA repair and the skin barrier. In one model studied, the expression of miR-96 was reduced by 82%. From this, the manufacturer infers potential support for downstream repair factors such as REV1, RAD51, and IGF1R.
In addition, the following properties are described:
- antioxidant protection,
- inhibition of COX-2,
- reduction of pollutant-induced inflammatory mediators,
- modulation of 21 skin-relevant genes,
- support for natural repair processes following UV and environmental stress.
This makes DermalRx® FSE particularly suitable for epigenetic skincare, which combines DNA protection, anti-pollution, and regeneration. Of course, the active ingredient is no substitute for sunscreen and must not be marketed as protection against UV radiation without a properly tested sunscreen formulation.
Suitable Applications
- regenerating day cream,
- night serums for environmentally stressed skin,
- pre- and post-sun products,
- anti-pollution serums,
- after-travel or urban recovery masks,
- soothing care following cosmetic procedures,
- BB and CC creams.
Volpura® EPO – Volume Restoration as a Component of Healthy Aging
Not every age-related change is due exclusively to a loss of collagen or elastin. Changes in subcutaneous fat tissue and fat compartments also influence facial contours. With age, the cheeks, temples, lips, and perioral region can lose volume. As a result, the face may appear narrower, more sunken, or more tired.
Volpura® EPO therefore takes a different approach than traditional anti-wrinkle ingredients. The active ingredient is based on a plant-derived technology centered on evening primrose oil (Oenothera biennis) and is designed to support lipid storage and volume restoration in adipose tissue models.
According to results provided by the manufacturer, the following improvements, among others, were observed when appropriate test formulations were applied:
- up to 13% higher skin density,
- up to 15% more volume,
- up to 29% better lip hydration,
- visibly fuller and more defined-looking lips and facial features.
These values are taken from the product dossier and should not be generalized to every formulation. Efficacy tests on the final formulation are required for specific claims.
Volpura® EPO complements epigenetic skincare with an aspect that has immediate visual relevance: the preservation of soft, harmonious facial contours. This approach may be particularly interesting in formulations designed for mature skin, very thin skin, or skin altered by rapid weight loss. However, direct references to pharmaceutical brands or the treatment of medically induced changes should be avoided in product communications.
Suitable Applications
- Plumping serums,
- lip care and lip boosters,
- cheek and contour care,
- rich night creams,
- neck and décolleté care,
- intensive masks for skin that appears lacking in volume.
Five active ingredients—five complementary approaches
The particular strength of the presented concept stems not from a single “hero ingredient,” but from the combination of different biological targets:
RNActivate™:
Modulation of a wrinkle-associated microRNA and support for type I collagen, elastin, and fibrillin.
TensylPro™:
Strengthening of the dermal-epidermal junction and extracellular matrix, as well as support for collagen III, collagen IV, elastin, laminins, and fibronectin.
DermalRx® Acetygen®:
Epigenetic HAT/HDAC regulation, support for cellular surveillance, and promotion of youth-associated gene expression patterns.
DermalRx® FSE:
Supports natural DNA repair following UV stress and provides antioxidant, anti-inflammatory, and anti-pollution properties.
Volpura® EPO:
A cosmetic volumizing and plumping approach for more defined and fuller-looking facial features.
This active ingredient architecture addresses RNA regulation, epigenetic gene control, cellular senescence, DNA repair, ECM stability, DEJ, inflammatory processes, and volume loss. As a result, epigenetic skincare can be positioned in a significantly more differentiated way than a traditional product that advertises solely on the basis of “more collagen.”
Six Innovative Product Proposals
- Epigenetic Longevity Serum
A lightweight premium serum with RNActivate™, DermalRx® Acetygen®, and a combination of ectoine, niacinamide, and hyaluronic acid.
Positioning: Epigenetic regeneration, improved skin firmness, and support for a youthful-looking skin structure.
Marketing idea: “Intelligent skincare, inspired by the skin’s cellular communication.”
- Collagen Banking & DEJ Concentrate
A concentrated serum with TensylPro™, peptides, and hydrating glycosaminoglycans.
Positioning: Early-stage skincare to support collagen, elastin, and the dermal-epidermal junction.
The concept is not limited to mature skin. Younger target groups, in particular, are increasingly interested in preventive routines designed to preserve existing skin structures for as long as possible.
- Overnight Epigenetic Reset Cream
A rich night cream with DermalRx® Acetygen®, RNActivate™, ceramides, phytosterols, and squalane.
Positioning: Supports nighttime regeneration and remodeling processes.
The formulation could be deliberately designed to have a modern, lightweight texture that spreads quickly and leaves a velvety after-feel.
- Urban DNA Recovery Fluid
A lightweight daytime fluid with DermalRx® FSE, antioxidants, ectoine, and skin-soothing active ingredients.
Positioning: Anti-pollution, protection against oxidative environmental stress, and support for natural DNA repair mechanisms.
As a daytime skincare product, it should ideally be combined with a separately tested sunscreen or developed directly as an SPF product and tested accordingly.
- Facial Volume & Lip Plumping Booster
A targeted booster with Volpura® EPO, low-molecular-weight hyaluronic acid, Tremella polysaccharides, and moisture-binding amino acids.
Positioning: For fuller, smoother, and more contoured-looking lips, cheeks, and the area around the mouth.
Its versatile use—both as a facial booster and as lip care—enhances the product’s appeal.
- Five-Dimension Skin Longevity Treatment
A luxurious treatment product that combines the presented mechanisms of action into a coordinated routine:
- Serum with RNActivate™ and DermalRx® Acetygen®,
- Gel-cream with TensylPro™,
- Recovery ampoule with DermalRx® FSE,
- Plumping concentrate with Volpura® EPO.
Instead of a single, overloaded product, the active ingredients can be distributed across two to four formulations. This facilitates stabilization, allows for concentrations tailored to efficacy, and simultaneously creates multiple marketable products based on a shared skin longevity concept.
The Future of Smart Anti-Aging Ingredients
Modern anti-aging research is increasingly moving away from the notion that skin aging can be controlled by a single active ingredient or a single signaling pathway. The Hallmarks of Aging, expanded in 2023, describe twelve interconnected biological mechanisms, including genomic instability, epigenetic changes, impaired cell communication, and cellular senescence.
This is precisely where the strength of epigenetic skincare lies: it views the skin not as a static surface, but as a dynamic network of cells, signaling molecules, gene regulation, and the extracellular matrix.
Nevertheless, objective communication is crucial. Cosmetic products can improve the appearance and condition of the skin but must not promise medical rejuvenation, genetic modification, or the healing of age-related cellular changes. Terms such as “DNA repair,” “gene activation,” or “zombie cells” should therefore be carefully examined, clearly contextualized, and supported by appropriate evidence of efficacy.
Conclusion
Epigenetic skincare represents a paradigm shift: away from the isolated treatment of individual wrinkles, toward long-term support of the skin’s biological resilience.
RNActivate™ targets microRNA-mediated regulatory processes. TensylPro™ strengthens the extracellular matrix and the dermal-epidermal junction. DermalRx® Acetygen® combines epigenetic regulation with remodeling and cell monitoring. DermalRx® FSE supports natural DNA repair processes following environmental stress. Volpura® EPO complements the concept with a cosmetic volumizing and plumping effect.
Together, these active ingredients enable scientifically advanced product concepts that combine skin longevity, healthy aging, collagen banking, DNA protection, and volume preservation into a modern skincare strategy.
Develop your own skin longevity cosmetics with Cosmacon
Would you like to develop an innovative product line based on epigenetic active ingredients, RNA technology, DNA repair, or ECM optimization?
We’ll guide you every step of the way—from the initial product idea through active ingredient selection, formulation development, and stability testing, all the way to regulatory evaluation and market launch. Together, we’ll develop scientifically sound cosmetic products that translate current trends such as epigenetic skincare, skin longevity, healthy aging, and collagen banking into market-ready formulations. Feel free to inquire right away…
For an exceptionally fast time-to-market, Tojo Cosmetics also offers a comprehensive portfolio of modern white-label cosmetic products. Existing serums, ampoules, creams, masks, and boosters can be selected and customized to match your brand, target audience, and positioning.
References
- López-Otín C. et al.: Hallmarks of Aging: An Expanding Universe. Cell, 2023.
- Publicly accessible publication
- Rittié L., Fisher G. J.: Natural and Sun-Induced Aging of Human Skin. Cold Spring Harbor Perspectives in Medicine, 2015.
- Publicly accessible full text
- Quan T., Fisher G. J.: Role of Age-Associated Alterations of the Dermal Extracellular Matrix Microenvironment in Human Skin Aging. Gerontology, 2015.
- Open-access full text
- Krützfeldt J. et al.: Silencing of microRNAs in vivo with “antagomirs”. Nature, 2005.
- PubMed entry with DOI
- Shin J. W. et al.: Molecular Mechanisms of Dermal Aging and Anti-Aging Approaches. International Journal of Molecular Sciences, 2019.
- Open-access full text
- McCabe M. C. et al.: Alterations in Extracellular Matrix Composition during Aging and Photoaging of the Skin.Matrix Biology Plus, 2020.
- Open-access full text
- Biocogent: Product dossiers on RNActivate™, TensylPro™, DermalRx® Acetygen®, DermalRx® FSE, and Volpura® EPO. The material-specific efficacy claims in this article are based primarily on studies provided by the manufacturer.